You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 1
  • LSO-092 Safety, efficacy and pharmacodynamics of cenerimod in patients with systemic lupus erythematosus: two randomised, double-blind phase 2 clinical trials

Article metrics

Article menu

Download PDFPDF

Short Oral Presentation
Short oral presentation session 16: SLE treatment 2
LSO-092 Safety, efficacy and pharmacodynamics of cenerimod in patients with systemic lupus erythematosus: two randomised, double-blind phase 2 clinical trials

 

Online download statistics by month:

Online download statistics by month: August 2023 to August 2024

AbstractFullPdf
Aug 20235107
Sep 20232306
Oct 20232204
Nov 20232404
Dec 2023601
Jan 20244101
Feb 202442013
Mar 202443012
Apr 20247408
May 20243502
Jun 20246704
Jul 202447013
Aug 20244708
Total522083